Treatment of Respiratory Tract Infection and/or Acute Bronchitis With Ectoin Inhalation Solution

Bitop

Status: Completed

Conditions: Sputum, Cellular Atypia; Cough; Bronchitis; Dyspnoea

Study type: Observational

Funder types: Industry

Identifiers

NCT02632851

EIL/aBr/2015

Details and patient eligibility

About

This observational, non-interventional multicentric study compares the inhalation therapy on patients suffering on respiratory tract infections and/or acute bronchitis between Ectoin inhalation solution and Pari NaCl (0.9%) inhalation solution

Full description

The assessment focuses on the bronchitis Severity Score (BSS) for standardized use in clinical studies with the outcome criteria of cough, sputum production, rales/rhonchi, chest pain during coughing and dysnoea

Enrollment: 135 patients

Sex: All

Ages: 5+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• according to instruction for use

Exclusion criteria

• according to instruction for use

Trial design

135 participants in 2 patient groups

Ectoin inhalation solution

Description:

treatment according to instructions for use

Pari NaCl inhalation solution (0.9%)

Description:

treatment according to instructions for use